Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.

Saved in:
Bibliographic Details
Title: Conventional radical versus focal treatment for localised prostate cancer: a propensity score weighted comparison of 6-year tumour control.
Authors: van Son MJ; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK. M.J.vanSon-3@umcutrecht.nl.; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK. M.J.vanSon-3@umcutrecht.nl.; Department of Radiotherapy, University Medical Centre Utrecht, Utrecht, The Netherlands. M.J.vanSon-3@umcutrecht.nl., Peters M; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Reddy D; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Shah TT; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Sunderland Royal Hospital, City Hospital Foundation Trust, Sunderland, UK., Hosking-Jervis F; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK., Robinson S; Division of Clinical Oncology, Department of Radiotherapy, Charing Cross Hospital, Imperial College London Healthcare NHS Trust, London, UK., Lagendijk JJW; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Mangar S; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK., Dudderidge T; Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK., McCracken S; Department of Urology, Sunderland Royal Hospital, City Hospital Foundation Trust, Sunderland, UK., Hindley RG; Department of Urology, Hampshire Hospitals & Ain Shams University Hospitals, Basingstoke, UK., Emara A; Department of Urology, Hampshire Hospitals & Ain Shams University Hospitals, Basingstoke, UK., Nigam R; BMI Mount Alvernia Hospital, Guildford, Surrey, UK., Persad R; Department of Urology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK., Virdi J; Department of Urology, Princes Alexandra Hospital NHS Trust, Harlow, UK.; Rivers Hospital, Essex, UK., Lewi H; Springfield Hospital, Chelmsford, UK., Moore C; Department of Surgery and Interventional Sciences, University College London, and University College Hospital London, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Orczyk C; Department of Surgery and Interventional Sciences, University College London, and University College Hospital London, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Emberton M; Department of Surgery and Interventional Sciences, University College London, and University College Hospital London, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Arya M; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK.; Department of Urology, Princes Alexandra Hospital NHS Trust, Harlow, UK.; Rivers Hospital, Essex, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Ahmed HU; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK., van der Voort van Zyp JRN; Department of Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, UK., Winkler M; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK., Falconer A; Imperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Imperial Urology, Imperial College Healthcare NHS Trust, London, UK.
Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2021 Dec; Vol. 24 (4), pp. 1120-1128. Date of Electronic Publication: 2021 May 01.
Publication Type: Comparative Study; Journal Article; Multicenter Study
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5608
DOI:10.1038/s41391-021-00369-6